Profiles

Keywords
Last Name
Institution

Terry Lichtor

Concepts (150)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
10
2009
177
1.770
Why?
Arnold-Chiari Malformation
5
2015
15
1.460
Why?
Fibroblasts
7
2008
96
1.420
Why?
Cancer Vaccines
4
2012
21
1.320
Why?
Interleukin-2
7
2008
96
1.230
Why?
Cerebrospinal Fluid
5
2005
23
1.100
Why?
Glioma
8
2009
54
0.910
Why?
Intracranial Pressure
3
2006
24
0.680
Why?
Neoplasms
3
2015
247
0.680
Why?
Syringomyelia
2
2005
12
0.660
Why?
Arachnoid Cysts
2
2005
6
0.660
Why?
Cerebrospinal Fluid Pressure
2
2005
5
0.650
Why?
Antineoplastic Agents
4
2007
307
0.610
Why?
Cerebrovascular Circulation
2
2005
55
0.590
Why?
Vaccines, DNA
1
2012
8
0.520
Why?
Antigens, Neoplasm
1
2012
50
0.510
Why?
Mice
12
2012
1719
0.500
Why?
Magnetic Resonance Imaging
7
2015
1163
0.480
Why?
Compliance
3
2005
8
0.480
Why?
Mice, Inbred C3H
6
2012
34
0.470
Why?
PPAR gamma
2
2007
17
0.460
Why?
Thiazolidinediones
2
2007
21
0.460
Why?
Decompression, Surgical
3
2005
142
0.410
Why?
Breast Neoplasms
4
2008
414
0.390
Why?
Animals
12
2012
4985
0.360
Why?
T-Lymphocytes, Regulatory
4
2015
58
0.360
Why?
Amyloid beta-Peptides
2
2004
202
0.350
Why?
Mice, Inbred C57BL
8
2007
507
0.340
Why?
Mammary Neoplasms, Experimental
1
2005
3
0.340
Why?
DNA, Neoplasm
1
2005
30
0.330
Why?
Interleukins
1
2005
39
0.330
Why?
Antibodies, Anti-Idiotypic
1
2004
10
0.320
Why?
Third Ventricle
1
2004
4
0.320
Why?
Plaque, Amyloid
1
2004
136
0.290
Why?
Microglia
1
2004
112
0.290
Why?
T-Lymphocytes
3
2012
233
0.280
Why?
Gene Transfer Techniques
1
2002
36
0.260
Why?
Cell Line, Tumor
4
2009
281
0.220
Why?
Female
11
2015
16622
0.190
Why?
Aging
2
2004
1402
0.190
Why?
Treatment Outcome
5
2008
3508
0.180
Why?
H-2 Antigens
2
2008
2
0.180
Why?
Humans
14
2015
27786
0.180
Why?
Transfection
2
2008
151
0.180
Why?
Survival Analysis
3
2008
379
0.180
Why?
Genetic Heterogeneity
1
2015
8
0.170
Why?
Foramen Magnum
2
2005
5
0.170
Why?
Interferon-gamma
2
2008
115
0.170
Why?
Immune Evasion
1
2015
2
0.160
Why?
Molecular Targeted Therapy
1
2015
40
0.160
Why?
Headache
1
2015
47
0.160
Why?
Carcinogenesis
1
2015
19
0.160
Why?
Cell Line
2
2008
348
0.160
Why?
Neoplasm Transplantation
2
2005
25
0.150
Why?
Immune Tolerance
2
2015
25
0.150
Why?
Adult
6
2015
9100
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2009
206
0.140
Why?
Cytokines
2
2012
335
0.130
Why?
Killer Cells, Natural
1
2012
90
0.120
Why?
Time Factors
4
2004
1802
0.120
Why?
Cell Survival
2
2007
179
0.110
Why?
Transforming Growth Factor beta1
1
2009
42
0.110
Why?
Brain
3
2008
1368
0.100
Why?
DNA, Complementary
1
2008
35
0.100
Why?
Spleen
1
2008
54
0.100
Why?
Immunophenotyping
1
2008
79
0.100
Why?
Forkhead Transcription Factors
1
2008
28
0.100
Why?
Chromans
1
2007
3
0.090
Why?
Cell Culture Techniques
1
2007
44
0.090
Why?
Male
6
2015
16222
0.090
Why?
Manometry
1
2006
27
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
150
0.090
Why?
Sensitivity and Specificity
2
2006
591
0.090
Why?
Hydrocephalus
1
2006
27
0.090
Why?
Immunotherapy, Active
1
2006
4
0.090
Why?
Drug Therapy, Combination
1
2007
257
0.090
Why?
Gene Expression
2
2009
263
0.090
Why?
Case-Control Studies
2
2005
643
0.090
Why?
Image Interpretation, Computer-Assisted
1
2006
92
0.080
Why?
Interleukin-18
1
2005
10
0.080
Why?
Blood Flow Velocity
1
2005
25
0.080
Why?
Transplantation, Homologous
2
2003
271
0.080
Why?
Astrocytes
1
2007
122
0.080
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2005
31
0.080
Why?
Histocompatibility Antigens Class I
1
2005
19
0.080
Why?
Gene Expression Profiling
2
2003
165
0.080
Why?
Genetic Vectors
1
2005
67
0.080
Why?
Congo Red
1
2004
2
0.080
Why?
Regional Blood Flow
1
2004
18
0.080
Why?
Age Factors
2
2006
869
0.080
Why?
Staining and Labeling
1
2004
26
0.080
Why?
Amyloid beta-Protein Precursor
1
2004
13
0.080
Why?
Spinal Canal
1
2004
15
0.080
Why?
Skull
1
2004
22
0.080
Why?
Brain Stem
1
2004
25
0.080
Why?
Cell Count
1
2004
115
0.080
Why?
Interleukin-1
1
2004
93
0.080
Why?
Spinal Cord
1
2005
97
0.080
Why?
Melanoma, Experimental
1
2003
7
0.070
Why?
Immunotherapy, Adoptive
1
2003
8
0.070
Why?
Injections, Intralesional
1
2003
33
0.070
Why?
Analysis of Variance
1
2004
358
0.070
Why?
Mice, Transgenic
1
2004
281
0.070
Why?
RNA, Neoplasm
1
2003
14
0.070
Why?
Meningioma
1
2003
17
0.070
Why?
Immunohistochemistry
1
2004
490
0.070
Why?
Middle Aged
3
2015
10510
0.070
Why?
Genetic Therapy
1
2003
89
0.070
Why?
Nerve Tissue Proteins
1
2003
158
0.070
Why?
Tumor Cells, Cultured
1
2002
160
0.070
Why?
Models, Theoretical
1
2002
102
0.060
Why?
Membrane Proteins
1
2003
199
0.060
Why?
Hippocampus
1
2003
276
0.060
Why?
Adolescent
1
2005
2439
0.050
Why?
Signal Transduction
2
2015
544
0.050
Why?
Oligonucleotide Array Sequence Analysis
2
2009
77
0.040
Why?
Tumor Microenvironment
1
2015
12
0.040
Why?
Antineoplastic Agents, Phytogenic
1
2015
21
0.040
Why?
Hydrodynamics
1
2015
1
0.040
Why?
Valsalva Maneuver
1
2015
7
0.040
Why?
Tumor Escape
1
2015
2
0.040
Why?
Phytochemicals
1
2015
3
0.040
Why?
Antigen Presentation
1
2015
23
0.040
Why?
Drug Resistance, Neoplasm
1
2015
75
0.040
Why?
Aged
1
2005
9291
0.030
Why?
Coculture Techniques
1
2009
37
0.030
Why?
Culture Media, Conditioned
1
2009
32
0.030
Why?
Lymphocyte Activation
1
2009
219
0.020
Why?
RNA, Messenger
1
2009
354
0.020
Why?
Membrane Potential, Mitochondrial
1
2007
12
0.020
Why?
Lactic Acid
1
2007
16
0.020
Why?
Cell Death
1
2007
66
0.020
Why?
Glucose
1
2007
62
0.020
Why?
Transduction, Genetic
1
2006
22
0.020
Why?
Energy Metabolism
1
2007
78
0.020
Why?
Feasibility Studies
1
2006
241
0.020
Why?
Preoperative Care
1
2006
144
0.020
Why?
Dose-Response Relationship, Drug
1
2007
514
0.020
Why?
Disease Models, Animal
1
2009
790
0.020
Why?
Patient Selection
1
2006
243
0.020
Why?
Synaptosomal-Associated Protein 25
1
2003
3
0.020
Why?
Reproducibility of Results
1
2006
811
0.020
Why?
Immunity
1
2003
19
0.020
Why?
Prognosis
1
2006
969
0.020
Why?
Multigene Family
1
2002
13
0.020
Why?
Glioblastoma
1
2002
22
0.020
Why?
Phenotype
1
2003
347
0.020
Why?
Adenocarcinoma
1
2003
230
0.020
Why?
Gene Expression Regulation
1
2003
329
0.010
Why?
Algorithms
1
2003
397
0.010
Why?
Lichtor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description